Quinidine
Links shared publicly online about this topic
NUEDEXTA (Dextromethorphan, Quinidine sulfate) drug information from MPR
empr.com — “NUEDEXTA (Dextromethorphan, Quinidine sulfate) drug information for Pseudobulbar affect from MPR including side effects, drug interactions, dosing, contraindications and warnings/precautions.” View full resource at empr.com
Most Recently Shared on April 27, 2011 at 5:05 am By:
MPR News: NUEDEXTA: Monograph added. http://bit.ly/dPvBgu
Dextromethorphan/quinidine for pseudobulbar affect — Current Psychiatry Online
currentpsychiatry.com — “Dextromethorphan/quinidine for pseudobulbar affect — Current Psychiatry Online” View full resource at currentpsychiatry.com
Most Recently Shared on February 24, 2011 at 12:57 pm By:
Current Psychiatry Medical Journal and Psychiatry
Out of the Pipeline: Dextromethorphan/quinidine for pseudobulbar affect http://bit.ly/hiRL2P #pseudobulbar #PBA
AVANIR Pharmaceuticals receives patent for low-dose quinidine formulations of Zenvia to treat PBA
news-medical.net — “AVANIR Pharmaceuticals, Inc. today announced that the United States Patent and Trademark Office (USPTO) has issued the Company a new patent for its lead drug candidate Zenvia" (dextromethorphan/quinidine), extending the period of patent protection in the United States into late 2025. U.S. patent number 7,659,282 titled "Pharmaceutical Compositions Comprising Dextromethorphan and Quinidine for the Treatment of Neurological Disorders" was issued on February 9, 2010. The new patent will p” View full resource at news-medical.net
Most Recently Shared on February 10, 2010 at 2:27 pm By:
AVANIR Pharmaceuticals receives patent for low-dose quinidine formulations of Zenvia to treat PBA: AVANIR Pharmace... http://bit.ly/clEHcv
Medical News: CMSC-ACTRIMS: Cutting Quinidine Still Works in Combo Med - in Meeting Coverage, CMSC-ACTRIMS from MedPage Today
medpagetoday.com — “SAN ANTONIO -- Low-dose quinidine in combination with dextromethorphan reduces the frequency of uncontrollable laughing or crying in multiple sclerosis while improving patient safety versus high-dose” View full resource at medpagetoday.com
Most Recently Shared on June 5, 2010 at 6:28 pm By:
CMSC-ACTRIMS: Cutting Quinidine Still Works in Combo Med (CME/CE): SAN ANTONIO (MedPage Today) -- Low-dose quinidi... http://bit.ly/bBczSA
Avanir Pharmaceuticals Announces Phase III STAR Trial Results Published in Annals of Neurology - Drugs.com MedNews
drugs.com — “AVANIR Pharmaceuticals Announces Phase III STAR Trial Results Published in Annals of Neurology AVANIR Pharmaceuticals, Inc. (Nasdaq AVNR) today announced the el” View full resource at drugs.com
Most Recently Shared on September 14, 2010 at 2:17 pm By:
Drugs and Devices OW OW Health
Avanir Pharmaceuticals Announces Phase III STAR Trial Results Published in Annals of Neurology: AVANIR Pharma... http://bit.ly/bY1VxC #drug
AVANIR Pharmaceuticals Announces Phase III STAR Trial Results Published In Annals Of Neurology
medicalnewstoday.com — “AVANIR Pharmaceuticals, Inc. (Nasdaq: AVNR) announced the electronic publication of the results of the pivotal Phase III STAR trial of its investigational drug AVP-923 (dextromethorphan/qu” View full resource at medicalnewstoday.com
Most Recently Shared on September 15, 2010 at 1:32 pm By:
AVANIR Pharmaceuticals Announces Phase III STAR Trial Results Published In Annals Of Neurology http://mnt.to/3JMb #multiplesclerosis
theheart.org: trusted cardiology news and opinions
theheart.org — “The latest developments in cardiology and cardiovascular research, including heartwire news and commentary by some of the world's top cardiologists. Sign up for free.” View full resource at theheart.org
Most Recently Shared on March 10, 2011 at 7:55 pm By:
As quinidine fades, doctors ask Big Pharma to put patients before profits: The situation has gotten so bad that ... http://bit.ly/g99iNj
Avanir Pharmaceuticals Announces FDA Approval of Nuedexta
drugs.com — “Nuedexta (dextromethorphan hydrobromide and quinidine sulfate) is used to treat pseudobulbar affect. Includes Nuedexta side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on November 2, 2010 at 6:41 am By:
Avanir Pharmaceuticals Announces FDA Approval of Nuedexta - http://bit.ly/czapU6
AVANIR Pharmaceuticals To Present Zenvia Phase III Data At American Academy Of Neurology Annual Meeting
medicalnewstoday.com — “AVANIR Pharmaceuticals, Inc. (NASDAQ:AVNR), announced it will present three scientific posters featuring detailed Zenvia™ (dextromethorphan/quinidine) safety and efficacy data from the doubl” View full resource at medicalnewstoday.com
Most Recently Shared on April 8, 2010 at 4:10 pm By:
MNT Neurology News Neurology and Health News
AVANIR Pharmaceuticals To Present Zenvia Phase III Data At American Academy Of Neurology Annual Meeting http://mnt.to/3zYC #neurology
AVANIR Pharmaceuticals Presents Zenvia Phase III Safety Data At The American Academy Of Neurology Annual Meeting
medicalnewstoday.com — “AVANIR Pharmaceuticals, Inc. (NASDAQ:AVNR) announced the presentation of detailed data, including safety and tolerability data from the open-label extension as well as cardiac safety data from the” View full resource at medicalnewstoday.com
Most Recently Shared on April 18, 2010 at 12:05 pm By:
MNT Neurology News Neurology and Health News
AVANIR Pharmaceuticals Presents Zenvia Phase III Safety Data At The American Academy Of Neurology Annual Meeting http://mnt.to/3BnQ
AVANIR Pharmaceuticals Announces Zenvia Review Timeline Established By FDA With PDUFA Date Of October 30, 2010
medicalnewstoday.com — “AVANIR Pharmaceuticals, Inc. (NASDAQ: AVNR) announced that the U.S. Food and Drug Administration (FDA) has acknowledged receipt of the Company's Complete Response to the October 2006 Approvable Le” View full resource at medicalnewstoday.com
Most Recently Shared on May 19, 2010 at 8:16 am By:
MNT Neurology News Neurology and Health News
AVANIR Pharmaceuticals Announces Zenvia Review Timeline Established By FDA With PDUFA Date Of October 30, 2010 http://mnt.to/3CMt #neurology
AVANIR Pharmaceuticals Submits Complete Response To FDA Approvable Letter For Zenvia In PBA
medicalnewstoday.com — “AVANIR Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced the submission of its Complete Response to the October 2006 Approvable Letter issued by the U.S. Food and Drug Administration (FDA) for” View full resource at medicalnewstoday.com
Most Recently Shared on May 5, 2010 at 1:26 am By:
MNT Drug Approvals Health News
AVANIR Pharmaceuticals Submits Complete Response To FDA Approvable Letter For Zenvia In PBA http://mnt.to/3C7P #regulatory
Nuedexta Approved For Uncontrollable Laughing Or Crying (Pseudobulbar Affect)
medicalnewstoday.com — “Nuedexta (dextromethorphan hydrobromide and quinidine sulfate) has been approved in capsule form by the Food and Drug Administration (FDA) as the first line of treatment for uncontrolled laughing” View full resource at medicalnewstoday.com
Most Recently Shared on October 30, 2010 at 5:37 pm By:
Nuedexta Approved For Uncontrollable Laughing Or Crying (Pseudobulbar Affect) Nuedexta (dextromethorphan hydrobromide a.. http://dld.bz/4nh6
AVANIR Pharmaceuticals Announces FDA Approval Of NUEDEXTA™
medicalnewstoday.com — “AVANIR Pharmaceuticals, Inc. (Nasdaq: AVNR) announced that the U.S. Food and Drug Administration (FDA) has approved NUEDEXTA™ (dextromethorphan hydrobromide and quinidine sulfate) capsules,” View full resource at medicalnewstoday.com
Most Recently Shared on October 30, 2010 at 1:05 pm By:
MNT Drug Approvals Health News
AVANIR Pharmaceuticals Announces FDA Approval Of NUEDEXTA™ http://mnt.to/3LTB #regulatory
Family Medicine News & Articles - MDLinx - Dextromethorphan on #MDlinx
mdlinx.com — “Family Medicine News & Articles - MDLinx - Dextromethorphan on #MDlinx” View full resource at mdlinx.com
Most Recently Shared on September 23, 2010 at 7:35 am By:
Sandeep Pulim MD Health Communicator, Physician, and Doctor
Dextromethorphan Plus Ultra Low-Dose Quinidine (DMq) Reduces Pseudobulbar Affect: Annals of Neurology http://bit.ly/c5V4tU #GM #mdlinx
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Featuring the top 3 experts for this topic
-
MPR
eMPR.com provides up-to-date, concise drug information at the point-of-care.
-
Current Psychiatry
Current Psychiatry is a peer-reviewed psychiatry journal
-
News-Medical.Net
Medical News from Around the World
Advertisement
